Abstract
That usEPs could ablate tumors was a significant finding in the use of this technology for cancer therapy. The finding that usEPs could also induce immunity was a bonus for this treatment as possible immunotherapy. However, the data to support this immune induction by usEPs had several different sets of suggestive evidence. One approach showed slower tumor growth in immunocompetent mice vs. growth in immunodeficient mice. A second approach showed the slower growth of a secondary tumor after ablation of a primary tumor, suggesting that the primary treatment caused an immune response that slowed secondary tumor growth. The presence of CD4+ T-cells in the primary treated tumors and CD4+ cells in the untreated secondary tumor was used as evidence. However, the CD4+ cells require further characterization to differentiate CD4+ CD25+ Foxp3+ T-regulatory immunosuppressor cells (Tregs) from CD4+ CD44+ with the presence or absence of CD62L+ as T-central or T effector memory cells, respectively. The strongest evidence for usEP-induced immunity indicated the complete absence of secondary tumor growth after primary tumor treatment. Such responses were present in cancer models in the ectopic mouse liver, orthotopic mouse breast, and rat liver cancers. The absence of secondary tumor growth is called vaccine effects or in situ vaccination. Thus, the treatment of the primary tumor induces immunity and vaccinates the animals by the usEP treatment. The latter two cancers exhibited early decreases in immunosuppressor Tregs and myeloid-derived suppressor cells (MDSC), which resolve suppression of immune responses, and increases in dendritic cells (DCs) in the TME that could identify antigens and induced immunity. The rat liver cancer model also showed activation of the innate immune natural killer (NK) cells with specific activation markers in its TME and the presence of effector and central memory cells in the mouse breast and rat liver (TME), which were cytotoxic. An ectopic mouse pancreatic cancer model that did not show a vaccine effect failed to show a decrease in Tregs and MDSC in the TME and blood and did not show activated T-cells, suggesting immunosuppression prevented an immune response. Continued studies will determine immunity, cell death mechanisms, and ICD factors (calreticulin, ATP, and HMGB1) in other immunogenic cancer models.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ambros V (2004) The functions of animal microRNAs. Nature 431(7006):350–355
Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ (2001) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192(4):565–570
Badovinac VP, Porter BB, Harty JT (2002) Programmed contraction of CD8(+) T cells after infection. Nat Immunol 3(7):619–626
Badovinac VP, Messingham KA, Jabbari A, Haring JS, Harty JT (2005) Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 11(7):748–756
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297
Bartel DP (2018) Metazoan microRNAs. Cell 173(1):20–51
Barry M, Heibein JA, Pinkoski MJ, Lee SF, Moyer RW, Green DR, Bleackley RC (2000) Mol Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Cell Biol 20(11):3781–3794
Beebe SJ, Fox PM, Rec LH, Buescher ES, Somers K, Schoenbach KH (2002) Nanosecond pulsed electric field (nsPEF) effects on cells and tissues: apoptosis induction and tumor growth inhibition. IEEE Trans Plasma Sci 30:286–292
Beebe SJ, Fox PM, Rec LJ, Willis EL, Schoenbach KH (2003) Nanosecond, high-intensity pulsed electric fields induce apoptosis in human cells. FASEB J 17:1493–2145
Beebe SJ, Ford WE, Ren W, Chen X (2011) Pulse power ablation of melanoma with nanosecond pulsed electric fields. In: Morton R (ed) Treatment of metastatic melanoma. In Tech Croatia, pp 231–268. ISBN 978-953-307-574-7. https://doi.org/10.5772/22850
Beebe SJ, Lassiter BP, Guo S (2018) Nanopulse stimulation (NPS) induces tumor ablation and immunity in orthotopic 4T1 mouse breast cancer: a review. Cancers (basel) 10(4):97
Blank CU, Haining WN, Held W, Hogan PG, Kallies A, Lugli E, Lynn RC, Philip M, Rao A, Restifo NP, Schietinger A, Schumacher TN, Schwartzberg PL, Sharpe AH, Speiser DE, Wherry EJ, Youngblood BA, Zehn D (2019) Defining ‘T cell exhaustion'. Nat Rev Immunol 11:665–674
Boraschi D, Italiani P (2018) Innate immune memory: time for adopting a correct terminology. Front Immunol 9:799
Bunt SK, Sinha P, Clements VK et al (2006) Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol 176:284–290
Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, Schmitt E, Hamai A, Hervas-Stubbs S, Obeid M, Coutant F, Métivier D, Pichard E, Aucouturier P, Pierron G, Garrido C, Zitvogel L, Kroemer G (2005) Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 202(12):1691–1701
Cerwenka A, Lanier LL (2016) Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol 16(2):112–123
Chai LF, Prince E, Pillarisetty VG, Katz SC (2020) Challenges in assessing solid tumor responses to immunotherapy. Cancer Gene Ther 27(7–8):528–538
Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ (2007) Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27(4):635–646
Chen R, Sain NM, Harlow KT, Chen YJ, Shires PK, Heller R, Beebe SJ (2014) A protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fields. Eur J Cancer 50(15):2705–2713
Chen X, Kolb JF, Swanson RJ, Schoenbach KH, Beebe SJ (2010) Apoptosis initiation and angiogenesis inhibition: melanoma targets for nanosecond pulsed electric fields. Pigment Cell Melanoma Res 23:554–563
Chen X, Zhuang J, Kolb JF, Schoenbach KH, Beebe SJ (2012) Long term survival of mice with hepatocellular carcinoma after pulse power ablation with nanosecond pulsed electric fields. Technol Cancer Res Treat 11:83–93
Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, Hirashima M, Uede T, Takaoka A, Yagita H, Jinushi M (2012) Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 13(9):832–842
Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF, Park D, Woodson RI, Ostankovich M, Sharma P, Lysiak JJ, Harden TK, Leitinger N, Ravichandran KS (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461(7261):282–286
Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391(6662):43–50
Escors D (2014) Tumour immunogenicity, antigen presentation and immunological barriers in cancer immunotherapy. New J Sci 2014:734515
Fergusson JR, Fleming VM, Klenerman P (2011) CD161-Expressing hHuman T cells. Front Immunol 2:36
Fergusson JR, Smith KE, Fleming VM, Rajoriya N, Newell EW, Simmons R, Marchi E, Björkander S, Kang YH, Swadling L, Kurioka A, Sahgal N, Lockstone H, Baban D, Freeman GJ, Sverremark-Ekström E, Davis MM, Davenport MP, Venturi V, Ussher JE, Willberg CB, Klenerman P (2014) CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages. Cell Rep 9(3):1075–1088
Gabrielli S, Ortolani C, Del Zotto G, Luchetti F, Canonico B, Buccella F, Artico M, Papa S, Zamai L (2016) The memories of NK cells: innate-adaptive immune intrinsic crosstalk. J Immunol Res 2016:1376595
Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162–174
Gamrekelashvili J, Ormandy LA, Heimesaat MM, Kirschning CJ, Manns MP, Korangy F, Greten TF (2012) Primary sterile necrotic cells fail to cross-prime CD8(+) T cells. Oncoimmunology 1(7):1017–1026
Gardiner CM, Finlay DK (2017) What fuels natural killers? metabolism and NK cell responses. Front Immunol 8:367
Garg AD, Krysko DV, Vandenabeele P, Agostinis P (2012) The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 1(5):786–788
Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W (1995) Schulte-Hermann R In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21(5):1465–1468
Green DR, Ferguson T, Zitvogel L, Kroemer G (2009) Immunogenic and tolerogenic cell death. Nat Rev Immunol 9:353–363
Guo S, Jing Y, Burcus NI, Lassiter BP, Tanaz R, Heller R, Beebe SJ (2018) Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases. Int J Cancer 142(3):629–640
Guo ZS, Liu Z, Bartlett DL (2014) Oncolytic immunotherapy: dying the right way is a key to eliciting potent antitumor immunity. Front Oncol 4:74
Haabeth OA, Tveita AA, Fauskanger M, Schjesvold F, Lorvik KB, Hofgaard PO, Omholt H, Munthe LA, Dembic Z, Corthay A, Bogen B (2014) How do CD4(+) T cells detect and eliminate tumor cells that either lack or express MHC class II molecules? Front Immunol 5:174
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hazenberg MD, Spits H (2014) Human innate lymphoid cells. Blood 124(5):700–709
Hou W, Zhang Q, Yan Z, Chen R, Zeh HJ III, Kang R, Lotze MT, Tang D (2013) Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death Dis 4(12):e966
Inoue H, Tani K (2014) Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments. Cell Death Differ 21:39–49
Kroemer G, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72
Krysko DV, D’Herde K, Vandenabeele P (2006) Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11(10):1709–1726
Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, Faraoni R, Floyd M, Hunt JP, Lockhart DJ, Milanov ZV, Martin MD, Badovinac VP (2018) Defining memory CD8 T cell. Front Immunol 9:2692
Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA (2008) Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29(1):21–32
Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, Sukkurwala AQ, Menger L, Zitvogel L, Kroemer G (2011) Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev 30(1):61–69
Koo GB, Morgan MJ, Lee DG, Kim WJ, Yoon JH, Koo JS, Kim SI, Kim SJ, Son MK, Hong SS, Levy JM, Pollyea DA, Jordan CT, Yan P, Frankhouser D, Nicolet D, Maharry K, Marcucci G, Choi KS, Cho H, Thorburn A, Kim YS (2015) Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics. Cell Res 25:707–725
Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P (2012) Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 12:860–875
Lanier LL (2015) NKG2D Receptor and its ligands in host defense. Cancer Immunol Res 3(6):575–582
Lassiter BP, Guo S, Beebe SJ (2018) Nano-pulse stimulation ablates orthotopic rat hepatocellular carcinoma and induces innate and adaptive memory immune mechanisms that prevent recurrence. Cancers (basel) 10(3):69
Lieberman J (2010) Anatomy of a murder: how cytotoxic T cells and NK cells are activated, develop, and eliminate their targets. Immunol Rev 235:5–9
Ljunggren HG, Kärre K (1990) In search of the ‘missing self’: MHC molecules and NK cell recognition. Immunol Today 11(7):237–244
Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC (2003) Granzyme B: a natural born killer. Immunol Rev 193:31–38
Luckey CJ, Bhattacharya D, Goldrath AW, Weissman IL, Benoist C, Mathis D (2006) Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells. Proc Natl Acad Sci USA 103(9):3304–3309
Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ, Querci V, Fambrini M, Liotta F, Levings MK, Maggi E, Cosmi L, Romagnani S, Annunziato F (2010) CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol 40(8):2174–2181
Matassov D, Kagan T, Leblanc J, Sikorska M, Zakeri Z (2004) Measurement of apoptosis by DNA fragmentation. Methods Mol Biol 282:1–17
Martin MD, Badovinac VP (2018) Defining Memory CD8 T Cell. Front Immunol 9:2692
Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, Ghiringhelli F, di Virgilio F, Zitvogel L, Kroemer G (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334(6062):1573–1577
Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197–223
Moretta A, Marcenaro E, Parolini S, Ferlazzo G, Moretta L (2008) NK cells at the interface between innate and adaptive immunity. Cell Death Differ 15(2):226–233
Morotomi-Yano K, Oyadomari S, Akiyama H, Yano K (2012) Nanosecond pulsed electric fields act as a novel cellular stress that induces translational suppression accompanied by eIF2α phosphorylation and 4E-BP1 dephosphorylation. Exp Cell Res. 318(14):1733–1744
Morrison MJ, Pallares G, Patel HK, Kroemer G1, Galluzzi L, Kepp O, Zitvogel L (2013) Immunogenic cell death in cancer therapy. Annu Rev Immunol 31:51–72
Murdoch C, Muthana M, Coffelt SB et al (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8:618–631
Netea MG, Joosten LA, Latz E, Mills K, Natoli G, Stunnenberg HG, O'Neill LA, Xavier RJ (2016) Trained immunity: a program of innate immune memory in health and disease. Science 352:aaf1098
Nuccitelli R, Tran K, Lui K, Huynh J, Athos B, Kreis M, Nuccitelli P, De Fabo EC (2012) Non-thermal nanoelectroablation of UV-induced murine melanomas stimulates an immune response. Pigment Cell Melanoma Res 25(5):618–629
Nuccitelli R, McDaniel A, Anand S, Cha J, Mallon Z, Berridge JC, Uecker D (2017) Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death. J Immunother Cancer 5:32
Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, Métivier D, Larochette N, van Endert P, Ciccosanti F, Piacentini M, Zitvogel L, Kroemer G (2007) Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13(1):54–61
O’Brien KL, Finlay DK (2019) Immunometabolism and natural killer cell responses. Nat Rev Immunol 19(5):282–290
Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, Fimia GM, Kepp O, Piacentini M, Froehlich KU, van Endert P, Zitvogel L, Madeo F, Kroemer G (2008) The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 15(9):1499–1509
Rossi A, Pakhomova ON, Pakhomov AG, Weygandt S, Bulysheva AA, Murray LE, Mollica PA, Muratori C (2019) Mechanisms and immunogenicity of nsPEF-induced cell death in B16F10 melanoma tumors. Sci Rep 9:431
Poznanski SM, Barra NG, Ashkar AA, Schertzer JD (2018) Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function. Inflamm Res 67(10):813–828
Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418(6894):191–195
Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP, Greten TF (2003) Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 103(2):205–211
Schoenbach KH, Beebe SJ, Buescher ES (2001) Intracellular effect of ultrashort electrical pulses. Bioelectromagnetics 22(6):440–448
Schoenbach KH, Joshi RP, Kolb JF, Chen N, Stacey M, Buescher ES, Beebe SJ, Blackmon P (2004) Ultrashort electrical pulses open a new gateway into biological cells. Proc IEEE 92:1122–1137
Schoenbach KH, Joshi RP, Beebe SJ, Baum CE (2009) A Scaling Law for Membrane Permeabilization with Nanopulses. IEEE Trans Dielectrics Electr Insul 16:1224–1235
Schwartzberg PL, Sharpe AH, Speiser DE, Wherry EJ, Youngblood BA, Zehn D.Defining T cell exhaustion'.Nat Rev Immunol 19(11):665–674
Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI. Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood 99(4):1259–1266
Sun J, Beilke J, Lanier L (2009) Adaptive immune features of natural killer cells. Nature 457:557–561
Sun JC, Lanier LL (2011) NK cell development, homeostasis, and function: parallels with CD8+ T cells. Nat Rev Immunol. 11(10):645–657
Sun JC, Ugolini S, Vivier E (2014) Immunological memory within the innate immune system. EMBO J 17:1295–1303
Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G (1997) Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A. 94(2):701–706
Tang H, Qiao J, Fu YX (2016) Immunotherapy and tumor microenvironment. Cancer Lett 370(1):85–90
Tao K, Fang M, Alroy J, Sahagian GG (2008) Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8:228
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G (2008a) Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol 20(5):504–511
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L et al (2008b) Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 15:3–12
Trapani JA (1995) Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B. Aust N Z J Med 25(6):793–799
Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331(6013):44–49
Vucic D, Deshayes K, Ackerly H, Pisabarro MT, Kadkhodayan S, Fairbrother WJ, Dixit VM (2002) SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP). J Biol Chem 277(14):12275–12279
Williams MA, Bevan MJ (2007) Effector and memory CTL differentiation. Annu Rev Immunol 25:171–192
Wu RS, Kobie JJ, Besselsen DG, Fong TC, Mack VD, McEarchern JA, Akporiaye ET. Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma. Cancer Immunol Immunother 50:229–240
Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T (2000) Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer 88(Suppl 12):2979–2988
Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, Klein C, Pietrocola F, Vacchelli E, Souquere S, Sauvat A, Zitvogel L, Kepp O, Kroemer G (2016) Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology 5(6):e1149673
Zhang X, Zhang Y, Chen J, Wu Y, Zhang J, Wang J (2019) Nanosecond pulsed electric field inhibits malignant melanoma growth by inducing the change of systemic immunity. Med Oral Patol Oral Cir Bucal 24(4):e555–e561
Zhu J, Paul WE (2008) CD4 T cells: fates, functions, and faults. Blood 112(5):1557–1569
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Beebe, S.J. (2021). usEPs as a Possible Immunotherapy. In: Ultrashort Electric Pulse Effects in Biology and Medicine. Series in BioEngineering. Springer, Singapore. https://doi.org/10.1007/978-981-10-5113-5_19
Download citation
DOI: https://doi.org/10.1007/978-981-10-5113-5_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5112-8
Online ISBN: 978-981-10-5113-5
eBook Packages: EngineeringEngineering (R0)